Artificial Intelligence increases efficiencies and reduces bias for bioanalytical pharmacokinetic studies and anti-drug antibody statistical determinations

As the amounts and complexity of information available is increasing, AI and advanced computational techniques are playing a critical role in determining data accuracy and reviewing large bioanalytical data sets. AI is assisting in simulating activities associated with human intellect by not only processing and comprehending data, but also by thinking, acquiring new abilities, and adapting to new contexts and challenges. Therefore, the use of AI in the pharmaceutical industry can increase accuracy, reduce the human workload, remove bias and errors, as well as reduce the time taken to evaluate these data sets. Learn more in this white paper.